HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shozo Nishida Selected Research

rosemorgen

5/2008Neuroprotective effects of an extract from the inflamed skin of rabbits inoculated with vaccinia virus on glutamate-induced neurotoxicity in cultured neuronal cell line.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shozo Nishida Research Topics

Disease

41Neoplasms (Cancer)
05/2022 - 04/2002
22Neoplasm Metastasis (Metastasis)
05/2022 - 10/2002
13Multiple Myeloma
01/2021 - 01/2008
11Melanoma (Melanoma, Malignant)
12/2021 - 01/2007
9Stomach Neoplasms (Stomach Cancer)
05/2022 - 09/2012
8Breast Neoplasms (Breast Cancer)
06/2022 - 09/2013
8Traumatic Brain Injuries (Traumatic Brain Injury)
05/2013 - 02/2009
5Carcinoma (Carcinomatosis)
03/2021 - 10/2002
4Carcinogenesis
04/2022 - 01/2007
4Hyperalgesia
12/2020 - 05/2008
4Colorectal Neoplasms (Colorectal Cancer)
06/2020 - 06/2011
4Osteoporosis
02/2014 - 10/2003
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2020 - 01/2003
3Brain Injuries (Brain Injury)
11/2009 - 02/2009
2Nausea
06/2022 - 08/2013
2Vomiting
06/2022 - 08/2013
2Squamous Cell Carcinoma of Head and Neck
03/2021 - 01/2017
2Mucositis
01/2021 - 02/2018
2Pain (Aches)
12/2020 - 09/2017
2Peripheral Nervous System Diseases (PNS Diseases)
12/2020 - 06/2020
2Psoriasis (Pustulosis Palmaris et Plantaris)
09/2020 - 10/2014
2Multiple Sclerosis
09/2020 - 10/2014
2B-Cell Lymphoma (Lymphoma, B Cell)
04/2018 - 10/2014
2Osteolysis
03/2016 - 01/2008
2Metabolic Bone Diseases (Osteopenia)
02/2014 - 03/2005
2Cognitive Dysfunction
05/2013 - 01/2013
2Osteosarcoma (Osteogenic Sarcoma)
03/2012 - 04/2011
2Cerebral Infarction
02/2010 - 11/2009
1Weight Gain
06/2022
1Sleepiness
06/2022
1Sleep Initiation and Maintenance Disorders (Insomnia)
06/2022
1Polypoidal Choroidal Vasculopathy
05/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022
1Colonic Neoplasms (Colon Cancer)
05/2021

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
05/2022 - 01/2007
10Paclitaxel (Taxol)FDA LinkGeneric
05/2022 - 09/2012
9Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2019 - 01/2008
7Pharmaceutical PreparationsIBA
06/2022 - 10/2012
6Antineoplastic Agents (Antineoplastics)IBA
03/2021 - 10/2003
6NF-kappa B (NF-kB)IBA
09/2020 - 10/2009
5Oxaliplatin (Eloxatin)FDA LinkGeneric
05/2021 - 06/2011
5SurvivinIBA
03/2020 - 10/2012
5Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2019 - 07/2009
5mangiferinIBA
06/2016 - 03/2011
5Diphosphonates (Bisphosphonates)IBA
02/2014 - 03/2005
5Free RadicalsIBA
05/2013 - 11/2009
5YM 529IBA
03/2012 - 01/2003
4TamoxifenFDA LinkGeneric
06/2022 - 07/2009
4Cisplatin (Platino)FDA LinkGeneric
01/2021 - 08/2013
4Phosphotransferases (Kinase)IBA
01/2019 - 10/2004
4Protein Kinase CIBA
10/2018 - 12/2003
4Messenger RNA (mRNA)IBA
01/2016 - 01/2007
4NitrogenIBA
01/2013 - 10/2010
3Fluorouracil (Carac)FDA LinkGeneric
06/2022 - 02/2017
3Bortezomib (Velcade)FDA Link
01/2021 - 01/2018
3Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
10/2020 - 04/2011
3Dimethyl FumarateIBA
09/2020 - 10/2009
3Melphalan (Alkeran)FDA LinkGeneric
02/2020 - 10/2012
3Vincristine (Oncovin)FDA LinkGeneric
10/2018 - 04/2015
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018 - 12/2003
3geranylgeranyl pyrophosphate (geranylgeranyl diphosphate)IBA
10/2017 - 08/2011
3CytokinesIBA
01/2017 - 12/2003
2AntiemeticsIBA
06/2022 - 08/2013
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2022 - 02/2017
2Indicators and Reagents (Reagents)IBA
01/2021 - 07/2009
2Imatinib Mesylate (Gleevec)FDA Link
11/2020 - 06/2017
2Verapamil (Calan)FDA LinkGeneric
03/2020 - 01/2014
2Dasatinib (BMS 354825)FDA Link
03/2020 - 02/2019
2RANK LigandIBA
02/2019 - 09/2013
2Caspase 3 (Caspase-3)IBA
01/2019 - 01/2017
2FluvastatinFDA Link
01/2019 - 01/2008
2Protein Kinases (Protein Kinase)IBA
01/2018 - 09/2010
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2017 - 07/2016
2Monoclonal AntibodiesIBA
12/2013 - 12/2012
2Dexamethasone (Maxidex)FDA LinkGeneric
08/2013 - 06/2011
2Monomeric GTP-Binding ProteinsIBA
01/2013 - 10/2010
2Matrix Metalloproteinase 14 (MT1-MMP)IBA
03/2012 - 01/2007
2U 0126 (UO 126)IBA
03/2012 - 01/2007
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
03/2012 - 07/2009
2EdaravoneIBA
02/2010 - 11/2009
2Free Radical ScavengersIBA
02/2010 - 11/2009
2Amyloid (Amyloid Fibrils)IBA
04/2009 - 02/2009
2Ditiocarb (Sodium Diethyldithiocarbamate)FDA Link
10/2004 - 06/2002
2Proliferating Cell Nuclear Antigen (PCNA)IBA
10/2002 - 10/2002
1Antipsychotic Agents (Antipsychotics)IBA
06/2022
1Estrogen ReceptorsIBA
06/2022
1Gefitinib (Iressa)FDA Link
06/2022
1Olanzapine (Zyprexa)FDA Link
06/2022
1Epirubicin (Ellence)FDA LinkGeneric
06/2022
1Blood Glucose (Blood Sugar)IBA
06/2022
1Verteporfin (Visudyne)FDA Link
05/2022
1Sorafenib (BAY 43-9006)FDA Link
12/2021
1perifosineIBA
05/2021

Therapy/Procedure

20Therapeutics
06/2022 - 03/2005
19Drug Therapy (Chemotherapy)
06/2022 - 07/2011
2Chemoradiotherapy
01/2021 - 02/2018
2Drug Tapering
12/2020 - 01/2018
2Intravenous Administration
01/2019 - 09/2012
2TP protocol
10/2018 - 10/2018
2Duration of Therapy
09/2017 - 06/2011